Shares of Celsion (CLSN) soar 15.4% in premarket trading after the firm catches a Buy rating along with positive comments from Brean Murray on the strength of encouraging data it expects to see released on Celsion's ThermoDox treatment later this year. Analysts at Brean set a PT of $7 for CLSN - marking 267% upside potential.
Are you Bullish or Bearish on ?
Sentiment on ()
Thanks for sharing your thoughts.